<?xml version="1.0" encoding="UTF-8"?>
<p>However, like SARS-CoV and MERS-CoV, SARS-CoV-2 is capable of escaping the immune response [
 <xref rid="B48-ijms-21-05559" ref-type="bibr">48</xref>]. For example, SARS-CoV can successfully shift ubiquitination and enhance degradation of RIG-I/MDA5 RNA sensors, TLR3, TLR7 and TLR8 [
 <xref rid="B49-ijms-21-05559" ref-type="bibr">49</xref>]. Furthermore, SARS-CoV and possibly SARS-CoV-2 can suppress innate immune responses without triggering the anti-viral response machinery, by counteracting NFÎºB and TI IFN signaling [
 <xref rid="B50-ijms-21-05559" ref-type="bibr">50</xref>]. Moreover, protective immunity against SARS-CoV-2 has not been reported and the virus is capable of immune escape and proliferation in infected organs [
 <xref rid="B36-ijms-21-05559" ref-type="bibr">36</xref>].
</p>
